Please use this identifier to cite or link to this item:
https://doi.org/10.3389/fimmu.2021.682627
DC Field | Value | |
---|---|---|
dc.title | B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion | |
dc.contributor.author | Luu, Khang | |
dc.contributor.author | Schwarz, Herbert | |
dc.contributor.author | Lundqvist, Andreas | |
dc.date.accessioned | 2022-10-26T09:11:25Z | |
dc.date.available | 2022-10-26T09:11:25Z | |
dc.date.issued | 2021-06-01 | |
dc.identifier.citation | Luu, Khang, Schwarz, Herbert, Lundqvist, Andreas (2021-06-01). B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion. Frontiers in Immunology 12 : 682627. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2021.682627 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/233703 | |
dc.description.abstract | The discovery of immune checkpoints highlights the complexity of T cell signalling during an immune response. Upon activation, T cells express several molecules to regulate their function and to prevent overactivation. B7 homolog 7 (B7-H7) is expressed in tumours and associated with a worse prognosis. However, conflicting data regarding its function suggest that it can be both stimulatory and inhibitory. In this study we report that B7-H7 is also expressed on T cells upon cross-linking of CD3 and CD28 and that additional stimulation via CD137 further enhances the expression of B7-H7. B7-H7 is preferentially expressed on exhausted Th1 and Tc1 cells with an impaired secretion of TNF-? and IFN-?. Blockade of B7-H7 with its natural receptor, recombinant CD28H, enhances T cell proliferation and activation. Thus, B7-H7 represents another target for immunotherapy and a biomarker to select for active effector T cells with relevance for adoptive cell transfer therapy. © Copyright © 2021 Luu, Schwarz and Lundqvist. | |
dc.publisher | Frontiers Media S.A. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus OA2021 | |
dc.subject | exhaustion | |
dc.subject | immune checkpoint | |
dc.subject | immunology | |
dc.subject | immunotherapy | |
dc.subject | T lymphocyte | |
dc.type | Article | |
dc.contributor.department | PHYSIOLOGY | |
dc.description.doi | 10.3389/fimmu.2021.682627 | |
dc.description.sourcetitle | Frontiers in Immunology | |
dc.description.volume | 12 | |
dc.description.page | 682627 | |
dc.published.state | Published | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3389_fimmu_2021_682627.pdf | 3.02 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License